Then, the release of FEGCG and MPI can not only regulate PD-L1 signaling with IRF, STAT-1/pSTAT-1, and PD-L1 expression, but also induce apoptosis signaling with Bcl-2 and Bax expression in tumor cells. The gene discussed is BCL2; the disease is neoplasm.